Bay Shore Trust 4
4 · Telomir Pharmaceuticals, Inc. · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Bay Shore Trust
10% Owner
Transactions
- Gift
Common Stock (right to buy)
2024-11-21−100,000→ 2,339,025 total(indirect: By Trust)Exercise: $3.73From: 2023-06-15Exp: 2028-06-15→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Bona Fide Gift. No compensation was given to the donor for the gifting of securities.